期刊文献+

脑多形性胶质母细胞瘤水肿带大小与预后相关性的分析 被引量:4

The Potential Correlation between the Size of Peripheral Edema and Prognosis of Glioblastoma Multiforme
下载PDF
导出
摘要 目的评价肿瘤外周水肿带对脑多形性胶质母细胞瘤(GBM)的预后影响。方法回顾性分析74例接受适形放射治疗(CRT)多形性胶质母细胞瘤患者的资料。所有患者均经病理组织学证实,其中62例患者经手术全切或次全切术,12例仅行立体定向活检术。55例采用了不同方式的化疗,另外19例患者行单纯放疗,放疗剂量均为60Gy。结果中位生存期为13.9个月,1、2及3年总生存率分别为57.0%、18.0%和12.9%。水肿带最大径≤70mm者中位生存期为19.9个月,>70mm者为9.9个月(P<0.0001);水肿带与肿瘤最大径比值(E/T)≤1.8与>1.8者中位生存期分别为16.6个月和9.9个月(P=0.0004)。中位肿瘤进展时间为7.8个月,1、2年的局部控制率分别为22.4%和8.2%。结论肿瘤边缘水肿带大小以及与肿瘤的比值是影响GBM预后的重要因素,提示水肿带应包括在照射野内,同时在不增加并发症的前提下是否应进一步提高水肿带照射剂量? Objective To evaluate t the potential correlation between the size of peripheral edema and prognosis of glloblastoma multlforme. Methods Seventy-four patients with newly diagnosed GBM patients treated with CRT were analyzed retrospectively. All patients underwent surgery,total or subtotal resection in 62 cases,biopsy only in 12.55 patients received CRT combined with various chemotherapy and 19 patients treated with CRT alone. The most common dose of CRT delivered was 60 Gy in 30 fractions. Results The median overall survival was 13.9 months with 1-year,2-year and 3-year survival rate of 57.0%, 18.0% and 12.9 % ,respectively. Patients with small edema (diameter ≤ 70 mm) had longer survival (19.7 months vs. 9.6 months in those 〉 70 mm) (P 〈 0. 0001). And the ratio of edema/gross tumor≤1. 8(P = 0. 0004) inducted better outcome. The median time to tumor progression was 7.8 months (range 6.1 to 9.3 months). The actuarial 1 year and 2 years local control rates were 22.4% and 8.2 %, respectlvely.Conclusion The size of edema and ratio of edema/tumor is survival predictor for GBM. It is may suggest that the peripheral edema region should be included in the radiation volume and a high enough dose with permission of neurotoxlcity should be delivered.
出处 《实用癌症杂志》 2006年第6期607-609,共3页 The Practical Journal of Cancer
关键词 脑多形性胶质母细胞瘤 放射疗法 水肿带 预后因素 Glioblastoma multiforme Radlotherapy Peripheral edema Prognostic factors
  • 相关文献

参考文献1

二级参考文献20

  • 1[1]Smith V, Verhey L, Serago CF. Comparison of radiosurgery treatment modalities based on complication and control probabilities. Int J Radiat Oncol Biol Phys 1998;40:507-13.
  • 2[2]Kondziolka D, Glickinger JC, Bissonette DJ, et al. Survival benefitof stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 1997;41:776-85.
  • 3[3]Shrieve DC, Alexander E, Black PM, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and longterm outcome. J Neurosurg 1999;90:72-7.
  • 4[4]Gannett D, Stea B, Lulu B, et al. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Int J Radiat Oncol Biol Phys 1995;33:461-8.
  • 5[5]Larson DA, Gutin PH, McDermott M, et al. Gamma knife for gliomas: selection factors and survival. Int J Radiat Oncol Biol Phys 1996;36:1045-53.
  • 6[6]Chang EL, Won YD, Allen PK, et al. Hypofractionationated radiosurgery for elderly or younger low-performance status glioblastoma patients:outcome and prognostic factors. Int J Radiat Oncol Biol Phys 2003;56:519-28.
  • 7[7]Hodgson DC, Goumnerova LC, Loeffler JS, et al. Radiosurgery in the management of pediatric brain tumors. Int J Radiat Oncol Biol Phys 2001;50:929-35
  • 8[8]McDermott MW, Sneed PK, Chang SM, et al. Results of radiosurgery for recurrent gliomas. In: Kondziolka D ed. Radiosurgery. Basel: Karger; 1996.p.102-12.
  • 9[9]Buatti JM, Friedman WA, Bova FJ, et al. Linac radiosurgery for high-grade gliomas: the University of Florida experience. Int J Radiat Oncol Biol Phys 2001;50:929-35.
  • 10[10]Shepherd SF, Laing RW, Cosgrove VP, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997;37:393-8.

同被引文献40

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部